TY  - GEN
AU  - Kanda,J
AU  - Horwitz,M E
AU  - Long,G D
AU  - Gasparetto,C
AU  - Sullivan,K M
AU  - Chute,J P
AU  - Morris,A
AU  - Hennig,T
AU  - Li,Z
AU  - Chao,N J
AU  - Rizzieri,D A
TI  - Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
SN  - 1476-5365
PY  - 2012///0906
KW  - Adult
KW  - Aged
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Cyclophosphamide
KW  - Female
KW  - Graft Survival
KW  - Graft vs Host Disease
KW  - prevention & control
KW  - Hematopoietic Stem Cell Transplantation
KW  - adverse effects
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Reoperation
KW  - Retrospective Studies
KW  - Salvage Therapy
KW  - methods
KW  - Transplantation Conditioning
KW  - Transplantation, Homologous
KW  - Vidarabine
KW  - analogs & derivatives
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/bmt.2011.158
ER  -